THC Therapeutics, Inc.

$0.00+0.00%(+$0.00)
TickerSpark Score
43/100
Weak
60
Valuation
35
Profitability
60
Growth
32
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a THCT research report →

52-Week Range1% of range
Low $0.00
Current $0.00
High $0.10

Companythct.io

THC Therapeutics, Inc. operates in the wellness industry. It is involved in the development of dHydronator, a sanitizing herb dryer for drying and sanitizing of freshly harvested cannabis, other herbs, flowers, and tea leaves.

CEO
Scott A. Cox
IPO
2017
Employees
1
HQ
Las Vegas, NV, US

Price Chart

+366.67% · this period
$0.03$0.02$0.00May 19Nov 17May 19

Valuation

Market Cap
$54.41K
P/E
-0.12
P/S
0.00
P/B
-0.01
EV/EBITDA
-1.72
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
12.06%
ROIC
20.42%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-387,036 · 74.52%
EPS
$-0.01 · 74.18%
Op Income
$-493,912
FCF YoY
79.61%

Performance & Tape

52W High
$0.10
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
7.53
Avg Volume
7.67K

Get TickerSpark's AI analysis on THCT

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Sep 10, 13Smith Adrian J Rother1,000,000
Nov 14, 13TANAKA HIROother0
Sep 10, 13MANN JAMIEother0
Sep 10, 13MANN JAMIEother6,403,726
Jun 7, 10Ho Edenbuy5,000
May 28, 10Ho Edenbuy19,001
Mar 15, 10Ho Edenother0

Our THCT Coverage

We haven't published any research on THCT yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate THCT Report →

Similar Companies